Gilead Sciences Stock Widgets and Gadgets
GILD Stock | USD 67.03 0.08 0.12% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- GILD Gilead Sciences
- Latest Incyte Earnings Expected to Grow Should You Buy
- GILD 67.03 0.08
- Low 67.0
- High 67.68
- Alpha -0.42
- Beta 0.48
- Return On Equity 0.26
- Return On Asset 0.0978
- Profit Margin 0.21 %
- Operating Margin 0.42 %
- Current Valuation 100.73 B
- Shares Outstanding 1.25 B
- Shares Owned By Institutions 88.27 %
- Number Of Shares Shorted 22.57 M
- Price To Earning 359.42 X
- Price To Book 3.72 X
- Price To Sales 3.13 X
- Revenue 27.12 B
- Gross Profit 21.62 B
- EBITDA 7.61 B
- Net Income 5.61 B
- Cash And Equivalents 6.14 B
- Cash Per Share 4.90 X
- Total Debt 24.99 B
- Debt To Equity 1.30 %
- Current Ratio 1.43 X
- Book Value Per Share 18.32 X
- Cash Flow From Operations 8.01 B
- Short Ratio 3.06 X
- Earnings Per Share 4.50 X
- Price To Earnings To Growth 0.42 X
- Target Price 78.7
- Number Of Employees 18 K
- Beta 0.2
- Market Capitalization 83.58 B
- Total Asset 62.12 B
- Retained Earnings 16.3 B
- Working Capital 4.8 B
- Current Asset 1.18 B
- Current Liabilities 104.89 M
- Annual Yield 0.05 %
- Five Year Return 3.76 %
- Net Asset 62.12 B
- Last Dividend Paid 3.0
- Accumulation Distribution 0.01
- Daily Balance Of Power 0.1176
- Rate Of Daily Change 1.0
- Day Median Price 67.34
- Day Typical Price 67.24
- Market Facilitation Index 0.68
- Price Action Indicator (0.27)
- Period Momentum Indicator 0.08
- Relative Strength Index 31.93
Market Snapshot Widget Example
DAX Index Germany | 18,138 1.55 | |
Taiwan Weighted Taiwan | 19,599 0.97 | |
PSI 20 Stock Portugal | 6,593 1.19 | |
CROBEX Croatia | 2,787 0.58 | |
Budapest SE Hungary | 65,939 1.25 | |
IDX 30 Jakarta Indonesia | 470.35 0.61 | |
ISEQ 20 Price Ireland | 1,652 0.39 | |
NYSE Comp USA | 17,793 1.08 | |
Tel Aviv 35 Israel | 1,912 0.55 | |
Coreshares Index Tracker South Afric | 1,041 1.46 | |
IPC MEXICO Mexico | 56,634 0.41 | |
KL Technology Malaysia | 63.18 0.78 | |
IBEX 35 Index Spain | 11,075 1.70 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,581 0.75 | |
SPASX Dividend Opportunities Australia | 1,656 0.07 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,202 0.23 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,291 0.09 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,164 0.75 | |
Basic Materials Brazil | 5,842 2.07 | |
Swiss Leader Price Switzerland | 1,870 1.24 | |
Fondo Mutuo ETF Chile | 1,420 0.97 | |
Athens General Comp Greece | 1,448 1.93 | |
Stock Exchange Of Thailand | 1,357 0.59 | |
PX Prague Stock Czech Repub | 1,557 0.42 | |
THE PHILIPPINE STOCK Philippines | 6,507 0.97 | |
WIG 30 Poland | 3,078 0.76 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Gilead Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Gilead Sciences
Compare Gilead Sciences To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3 | Earnings Share 4.5 | Revenue Per Share 21.728 | Quarterly Revenue Growth (0.04) |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.